Washington: An expert committee convened by the US Food and Drug Administration (FDA) has voted heavily in favour of recommending the Pfizer-BioNTech COVID-19 vaccine for emergency use approval.
The final voting tally was 17 in favour, four against and one abstention on Thursday, news agency AFP reported.
The committee was tasked with answering whether, “based on the totality of scientific evidence available, do the benefits of the Pfizer-BioNTech COVID-19 vaccine outweigh its risk for use in individuals 16 years of age and older?”
The vote by the independent experts and researchers, including infectious disease specialists, biostatisticians and other scientists, isn’t binding, but the FDA is expected to follow the recommendation within the coming days.
Britain, Canada, Bahrain and Saudi Arabia have already approved the vaccine, the first in the world to complete a large-scale, phase 3 clinical trials.
In India, Pfizer was the first to apply to the Drug Controller General of India (DGCI) for emergency use approval for the vaccine.
Dubai: ODI cricket, Pakistan – they bring out the best in Virat Kohli. The Dubai… Read More
Cuttack: Three criminals were arrested by Choudwar police in Odisha’s Cuttack district for allegedly looting… Read More
Kolkata: Odisha FC fought gallantly in the lion’s den but finally returned empty-handed. Up against league… Read More
Kolkata: A West Bengal secondary board exam (Madhyamik) candidate recently took Artificial Intelligence (AI) to… Read More
New Delhi: A fourth batch of Indian nationals deported from the US arrived at Indira… Read More
Berhampur: Rushikulya river mouth in Odisha’s Ganjam district has emerged as a major rookery for… Read More
This website uses cookies.
